After a week of deliberation, a jury returned a guilty verdict on four charges related to wire fraud, each of which carries a maximum sentence of up to 20 years in prison.
Federal prosecutors filed criminal charges that allege the company’s promise to revolutionize blood testing swindled investors out of hundreds of millions of dollars and put patients in danger.
The company’s finger-prick tests yield cholesterol levels notably lower than results of traditional blood draw tests from two other large companies, according to a study.